期刊
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
卷 58, 期 7, 页码 1029-1036出版社
WALTER DE GRUYTER GMBH
DOI: 10.1515/cclm-2020-0502
关键词
antibodies; anticoagulation; autopsy; coagulation parameters; COVID-19; D-dimer; disseminated intravascular coagulation; heparin; low-molecular-weight heparin; pulmonary embolism; SARS-CoV-2; thrombosis
The timely and accurate diagnosis of infection with severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19), remains the cornerstone of efforts to provide appropriated treatment for patients, to limit further spread of the virus and ultimately to eliminate the virus from the human society. We focus this article on (a) developments for improvement of diagnosis of specific SARS-CoV-2 virus, (b) laboratory changes in the immunologic and coagulation system, (c) therapeutic options for anticoagulant treatment of seriously affected patients and (d) on the perspectives through improvement of diagnostic and therapeutic medical procedures.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据